Fig. 1From: Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosaThe transparent reporting of evaluations with non-randomized design (TREND) flow diagram. The TREND flow diagram describes the number of study participants during trial enrollment, allocation, follow-up, and discontinuation of intervention of the intravitreal injection of autologous bone marrow-derived mesenchymal stem cellsBack to article page